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        T cell  –  mediated immunity is critical for pro-
tection against   Mycobacterium tuberculosis   (  Mtb  ); 
mice and humans who lack T cells, are very 
susceptible to lethal disease (  1, 2  ). Nevertheless, 
this immunity seems to be subject to limitations. 
Even the most successful immune response 
against   Mtb   often manages only to contain, rather 
than eradicate, the organism. Furthermore, ani-
mals and humans persistently infected with   Mtb  , 
or who have been cured of tuberculosis by che-
motherapy, can be superinfected, or reinfected 
(  3  –  5  ). In light of these facts, it is perhaps not 
surprising that the currently used vaccine, BCG, 
which is an attenuated strain of   Mycobacterium 
bovis  , is largely ineff  ective (  6  ). What are the fac-
tors that prevent the immune system from eradi-
cating   Mtb   during primary infection, and even 
prevent an eff  ective memory response from oc-
curring at the time of a subsequent challenge? 
A better understanding of the reasons for these 
apparent defi  ciencies in the immune response 
against   Mtb   is needed for the rational design of 
an eff  ective vaccine. 
  The structure central to this   “  limited  ”   im-
mune response evoked by   Mtb   after aerosol 
infection is the granuloma, which is an orga-
nization of immune cells that contains viable 
bacilli (  3, 7  –  9  ). The granuloma is composed of 
an aggregation of macrophages containing intra-
cellular bacilli surrounded by a cuff   of lympho-
cytes, including CD4      T cells and CD8      T cells. 
Some of these T cells recognize   Mtb  -derived 
antigens and produce eff  ector cytokines, such 
as IFN-      and TNF-     , which promote mac-
rophage activation and control mycobacterial 
growth. In addition, other T cells express an 
activated phenotype, but do not produce eff  ec-
tor cytokines (  10  ). The granuloma serves the 
immune system by containing   Mtb   and limiting 
the extent of infl  ammation and tissue damage 
to the host. Conversely, the granuloma also 
serves the bacillus by providing a niche condu-
cive for its prolonged survival. The pathogen- 
and host-mediated mechanisms that generate and 
maintain this balanced immune response are 
poorly understood. 
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    Mycobacterium tuberculosis   (  Mtb  ) frequently establishes persistent infections that may be 
facilitated by mechanisms that dampen immunity. T regulatory (T reg) cells, a subset of 
CD4      T cells that are essential for preventing autoimmunity, can also suppress antimicrobial 
immune responses. We use Foxp3-GFP mice to track the activity of T reg cells after aerosol 
infection with   Mtb  . We report that during tuberculosis, T reg cells proliferate in the pulmo-
nary lymph nodes (pLNs), change their cell surface phenotype, and accumulate in the pLNs 
and lung at a rate parallel to the accumulation of effector T cells. In the   Mtb  -infected lung, 
T reg cells accumulate in high numbers in all sites where CD4      T cells are found, including 
perivascular/peribronchiolar regions and within lymphoid aggregates of granulomas. To 
determine the role of T reg cells in the immune response to tuberculosis, we generated 
mixed bone marrow chimeric mice in which all cells capable of expressing Foxp3 expressed 
Thy1.1. When T reg cells were depleted by administration of anti-Thy1.1 before aerosol 
infection with   Mtb  , we observed     1 log less of colony-forming units of   Mtb   in the lungs. 
Thus, after aerosol infection, T reg cells proliferate and accumulate at sites of infection, and 
have the capacity to suppress immune responses that contribute to the control of   Mtb  . 2160 T REGULATORY CELLS AND TUBERCULOSIS | Scott-Browne et al.
(Thy1.1-expressing). Using these mixed bone marrow chimeric 
mice, we were able to eliminate all cells capable of becoming 
Foxp3-expressing T reg cells in vivo using a depleting anti-
Thy1.1 antibody. 
    RESULTS   
  During tuberculosis, Foxp3 expression is restricted primarily 
to CD4     T cells 
  To characterize the phenotype and function of T reg cells 
during chronic infection, we infected Foxp3-GFP reporter 
mice with a low dose of   Mtb   (strain H37Rv) via aerosol-
ization. In uninfected mice, Foxp3 expression is limited to 
TCR-                cells, predominately in the CD4      subset (  25  ). Af-
ter aerosol infection with   Mtb  , Foxp3 expression remained 
limited to a subset of TCR-                cells (  Fig. 1 A  ), and within 
this population,      95% were CD4     .   Foxp3 was not expressed 
in TCR-               , NK1.1     , CD11b     , or CD11c      cells (unpub-
lished data). Thus, even during the highly infl  ammatory setting 
  Foxp3-expressing regulatory T (T reg) cells are a subset of 
CD4      T cells, most of which express the cell surface marker 
CD25. These cells are essential for preventing autoimmunity. 
Furthermore, T reg cells have recently been shown to also 
suppress antimicrobial immune responses, especially against 
pathogens that establish persistent infections (  11  ). In the most 
well-characterized example, T reg cells have been shown to be 
essential for establishing and maintaining persistent infection by 
  Leishmania major   (  12  –  14  ); elimination of T reg cells in persis-
tently infected mice resulted in the eradication of the parasite 
from the host (  12  ). In addition, T reg cells protect the host dur-
ing infections by preventing collateral damage to the host  ’  s 
tissue from excessive infl  ammation induced by the immune 
response to the pathogen (  11  ). Although T reg cells have been 
studied mostly in respect to persistent viral and parasitic infec-
tions (  11  ), their involvement has also been implicated in bacte-
rial infections, including infections caused by   Helicobacter pylori   
(  15  –  18  ) and   Listeria monocytogenes   (  19  ). The role of T reg cells 
in suppressing immunity to   Mtb  , which is the most important 
bacterial pathogen that establishes a persistent infection in 
humans in terms of morbidity and mortality, is only begin-
ning to be investigated. In human tuberculosis, three studies 
have shown an increase in T reg numbers in the blood and at 
sites of infection during active disease (  20  –  22  ). In the murine 
model, there are two studies that have reached diff  erent con-
clusions about the role of T reg cells in tuberculosis. Quinn 
et al. (  23  ) used anti-CD25 antibodies to reduce the number of 
T reg cells in mice. Although they observed increased IFN-      
production at early time points after infection, this depletion 
did not aff  ect the bacterial load. Using a diff  erent strategy, 
Kursar et al. (  24  ) adoptively transferred CD25-negative CD4      
T cells with and without CD25      T cells into T cell  –  defi  cient 
(RAG       /      ) recipients before infection with   Mtb  ; these inves-
tigators did observe a lower bacterial load when the number 
of T reg cells in the recipients was reduced. We seek to further 
investigate the role of T reg cells in tuberculosis using the 
murine model. 
  Monitoring the activity and targeting the depletion of 
T reg cells during tuberculosis is complicated by the lack of 
good markers that identify these cells. As in the above studies, 
expression of CD25 is commonly used to identify CD4      
T reg cells, and anti-CD25 antibodies have been used to 
deplete this population. However, these approaches are prob-
lematic during ongoing   Mtb   infection because CD25 is up-
regulated on eff  ector T cells, and furthermore, CD25 is not 
expressed on all T reg cells (  25  ). We describe two approaches 
to circumvent these problems. First, we have used mice ex-
pressing GFP knocked into the locus encoding the forkhead 
transcription factor, Foxp3 (  25  ). In mice, Foxp3 is uniquely ex-
pressed in T reg cells and, in fact, is responsible for promoting 
the transcriptional program that conveys T regulatory cell 
development and function (  26  ). Thus, T reg cells could be 
tracked by their expression of Foxp3-GFP fusion protein in-
dependently of CD25 expression. Second, we have reconsti-
tuted irradiated recipients with bone marrow from Foxp3  °   
donors (Thy1.2 expressing) and wild-type B6.PL donors 
  Figure 1.     Characterization of Foxp3-expressing cells in   Mtb  -
  infected mice. (A) PLNs from Foxp3-GFP mice 56 d after aerosol infection 
with   Mtb   were stained for TCR     , CD4, and CD8. FACS plots are gated on 
live cells or live FoxP3-GFP  cells. Similar data were obtained gating on 
cells in the spleen and lung and are representative of two mice in two 
different experiments. (B) The percentage of CD4  cells that express 
Foxp3-GFP are shown for lung, pLN, spleen, and mLN 21, 64, and 127 d 
after infection, as indicated, for uninfected mice (open bars) and infected 
mice (shaded bars). Numbers represent the mean of three mice per group   
the SD for infected LNs and the mean of two mice for uninfected LNs. 
Lung numbers represent a pool of six lobes, two from each of three in-
fected mice, and three each from each of two uninfected mice. Data is 
representative of four independent experiments. (C) Total numbers of 
CD4  Foxp3-GFP  cells are shown for lungs and pLNs at 21, 64, and 127 d 
after infection (black bars). Age-matched controls are shown in white 
bars. Numbers represent the mean of three mice per group   the SD for 
infected LNs and the mean of two mice for uninfected LNs. Lung numbers 
represent a pool of six lobes, two from each of three infected mice, and 
three each from each of two uninfected mice. Data are representative of 
four independent experiments. (D) Mice infected with   Mtb   (or  uninfected 
controls) were administered BrdU in drinking water beginning 21 d after 
infection. 14 d later, cells from pLN and mLN from   Mtb -infected  mice 
(black bars) or uninfected controls (white bars) were stained for CD4, and 
the percentage of CD4 , BrdU  cells were compared between Foxp3-
GFP  and Foxp3-GFP  –  negative cells in pLNs and mLNs. Data represent the 
mean of three mice per group   the SD.     JEM VOL. 204, September 3, 2007 
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infected mice or from uninfected controls with anti-Foxp3 
antibodies. Control sections were stained with nonspecifi  c 
rabbit IgG. In uninfected mice, the few Foxp3-expressing 
cells observed were seen in perivascular and peribronchiolar 
regions (  Fig. 2 A  ).   In microscopic fi  elds containing vascular 
and bronchial structures, we counted 1  –  15 Foxp3-expressing 
cells at 200      magnifi  cation. Almost no T reg cells were 
observed in the parenchyma or other sites within the lung 
(unpublished data). In   Mtb  -infected mice (40  –  120 d after infec-
tion),     70  –  90% of the lungs were normal in appearance and 
did not display the infl  ammatory changes associated with the 
of tuberculosis, Foxp3 expression is remarkably restricted to 
a subset of CD4      T cells. 
  Foxp3      cells accumulate in the lungs and pulmonary 
lymph nodes (pLNs) 
  The immune response to   Mtb   after aerosol infection includes 
a dramatic expansion of lymphocytes in the pLNs and mi-
gration of eff  ector cells into the lungs (  2  ). We compared 
the percentage of Foxp3-expressing CD4      T cells in various 
tissues after aerosol infection with   Mtb  . Over time, the per-
centage of CD4      cells expressing Foxp3 increased in both 
infected and uninfected mice as they aged (  Fig. 1 B  ). However, 
the percentage at each time point was similar in both infected 
and uninfected mice in all tissues examined (i.e., lungs, pLNs 
[draining the lungs], spleen, and mesenteric LNs [mLNs; 
distal to the infection]). Interestingly, the LNs and spleen 
contained a higher percentage of Foxp3-expressing CD4      
T cells than the lungs, both before and at all time points after 
infection. Although the T reg population remained a con-
stant percentage of CD4      T cells in each respective tissue, 
the absolute number of Foxp3-expressing cells increased 
dramatically at sites of infection as the number of total CD4      
T cells increased. Even 21 d after infection, the number of 
Foxp3-expressing CD4      T cells was elevated at sites of 
infection, and by later time points had increased     5- and 
20-fold in the lungs and pLNs, respectively (  Fig. 1 C  ). The 
number of Foxp3-expressing cells did not increase in mLNs 
distal to the site of infection (unpublished data). Overall, our 
results indicate that expansion of T reg cells parallels the ex-
pansion of CD4      eff  ector T cells in the lung and pLNs after 
aerosol infection. 
  Our fl  ow cytometric results suggested that the most pro-
found accumulation of T reg cells after aerosol infection with 
  Mtb   occurred in the pLNs, but this could refl  ect either 
recruitment or increased proliferation. To address this question, 
we administered BrdU in the drinking water of Foxp3-GFP 
mice 3 wk after aerosol infection, a time when this accumula-
tion was marked. Proliferation of T cells in vivo in pLNs and 
mLNs between infected and uninfected animals was compared 
by incorporation of BrdU. As shown in   Fig. 1 D  , the per-
centage of Foxp3      cells that incorporated BrdU increased by 
73% in the pLNs of infected animals (52 vs. 30%), compared 
with uninfected controls. Not surprisingly, BrdU incorpor-
ation in Foxp3-negative cells was also increased in the pLNs 
of infected mice, albeit to a lesser degree (47% increase). In 
the mLNs, distal to the site of infection, the percentages of 
Foxp3-expressing and -negative CD4      T cells that incorpo-
rated BrdU were similar in infected and uninfected animals. 
These data indicate that the accumulation of T reg cells in the 
pLNs after aerosol infection refl  ects, at least in part, an in-
creased proliferation of these cells. 
  Foxp3-expressing T reg cells reside in pulmonary 
granulomas during tuberculosis 
  To determine the location of T reg cells within the lung 
during tuberculosis, we stained lung sections from   Mtb  -
  Figure 2.     Localization of T reg cells in lungs of infected mice. 
(A) Representative sections showing perivascular areas from lungs of 
uninfected or   Mtb  -infected mice (115 d after infection) stained with anti-
Foxp3 (green) and anti  –  E-cadherin (red) to stain respiratory epithelium. 
(B) Serial sections showing parenchymal granuloma of an   Mtb -infected 
mouse (    60 d after infection) stained with anti-Foxp3 (green) and CD4 
(red; left) and hematoxylin/eosin (right). Section is representative of sec-
tions of eight mice examined, ranging from 40 to 120 d after infection. 
(C) Serial sections showing parenchymal granuloma of an   Mtb -infected 
mouse stained with nonspecifi  c rabbit IgG (green) and CD4 (red; left), and 
hematoxylin/eosin (right). Although the nonspecifi  c green fl  uorescence of 
macrophages was similar to the section in B, the green pinpoint staining 
of nuclei within the CD4  region of the granuloma (as seen in B using 
anti-Foxp3) was not seen using nonspecifi  c polyclonal rabbit IgG as the 
primary antibodies. Bars, 50     m.   2162 T REGULATORY CELLS AND TUBERCULOSIS | Scott-Browne et al.
  regions of granulomas, which are immediately adjacent to 
infected macrophages. 
  Foxp3-expressing T reg cells in tuberculosis do not produce 
effector cytokines or IL-10 
  Eff  ector T cells, in response to antigenic stimulation, can de-
velop the ability to make proinfl  ammatory cytokines such as 
IFN-      and TNF-     , whereas T reg cells are generally unable 
to make these cytokines (  28  ). To determine if the cytokine 
production of Foxp3-expressing cells is altered during chronic 
infection, cells from the pLNs and lung were stimulated ex vivo 
with anti-CD3 and -CD28 in the presence of monensin. 
Compared with CD4     , Foxp3-GFP  –  negative cells, the CD4      
Foxp3-GFP  –  expressing cells did not acquire the ability to 
rapidly make the infl  ammatory cytokines IFN-      or TNF-      
upon restimulation (  Fig. 3  ).   In the lung, 6 and 12.3% of 
Foxp3-negative CD4      T cells produced IFN-      or TNF-     , 
respectively, whereas      1% of Foxp3      CD4s produced these 
cytokines. Similar results were observed using pLN cells, 
where the percentage of Foxp3-expressing CD4s capable 
of producing infl  ammatory cytokines was 10-fold less than 
Foxp3-negative CD4s (  Fig. 3  ). 
  Because IL-10 has been shown to be an important me-
diator of immunosuppression used by T reg cells in some, 
but not all, experimental systems (  29  ), we also tested their 
ability to produce IL-10 using intracellular cytokine staining. 
We were unable to detect IL-10 production after polyclonal 
stimulation with both anti-CD3 and -CD28 or after stimula-
tion with PMA and ionomycin at any time point after infec-
tion (unpublished data). Thus, we believe it is unlikely that 
IL-10 produced by T reg cells plays a major role in T reg 
cell  –  mediated immunosuppression in tuberculosis, at least in 
B6 mice. However, other suppressive pathways, such as 
TGF-     , cell  –  cell contact mediated by CTLA-4, or other 
mechanisms may be involved. 
infection. In these noninfl  amed regions of the lung, only 
a few T reg cells were observed, similar in number and distri-
bution to those seen in uninfected mice (unpublished data). 
In striking contrast, in regions of the lungs showing infl  am-
matory changes (i.e.,     10  –  30% of the lung), high numbers 
of Foxp3-expressing cells were observed in all regions of the 
lung that contained aggregates of lymphocytes (  Figs. 2, 
A and B  ). Refl  ecting pulmonary locations previously described 
for CD4      T cells in tuberculosis (  27  ), Foxp3-expressing cells 
were found in abundance in the perivascular and peribron-
chiolar regions (  Fig. 2 A  ) and within the lymphoid aggregates 
of granulomas (  Fig. 2 B  ); at these sites, the T reg cells were 
distributed evenly throughout the aggregates. In the infl  amed 
regions of   Mtb  -infected lungs, most microscopic fi  elds con-
tained      300 Foxp3-expressing cells at 200      magnifi  cation. 
Although many macrophages associated with granulomas dis-
played nonspecifi  c, cytoplasmic green fl  uorescence (  Fig. 2, 
B and C  ), the distinctive staining of T reg cells, represented by 
the staining of the nuclei of a subset of lymphocytes, was only 
observed when the anti-Foxp3 primary antibody was used 
(  Fig. 2, A and B  ). Although a precise quantifi  cation of the 
total number of T reg cells in the lungs is not possible using 
immunohistochemical techniques, we saw more T reg cells 
in the lungs of   Mtb  -infected mice relative to uninfected con-
trols than we did by fl  ow cytometry (where we observed a 
relatively modest     5      increase in the number of T reg cells 
in the lung;   Fig. 1 C  ). Thus, we believe it is possible that fl  ow 
cytometry underestimates the true number of T reg cells that 
accumulate in the lung in tuberculosis, and that collagenase 
digestion may not effi   ciently isolate all the T reg cells from 
  Mtb  -infected lungs. 
  To further defi  ne the location of T reg cells relative to 
tuberculous bacilli within the lung, we infected mice with 
  Mtb   expressing recombinant red fl  uorescent protein (RFP). 
Lung sections were examined at various time points after 
infection to determine the locations of RFP-expressing bacilli 
and Foxp3-expressing cells. Bacilli were observed primarily 
within macrophages displaying nonspecifi  c green fl  uorescence. 
Some of these infected macrophages were located within 
the center of granulomas (Fig. S1, B and C, available at 
http://www.jem.org/cgi/content/full/jem.20062105/DC1), 
and others were distributed around the periphery of the gran-
ulomas (Fig. S1 A, top right). Occasionally, bacilli were seen 
outside of green cells, probably representing either extra-
cellular bacilli or bacilli within fi  broblasts or epithelial cells 
(Fig. S1 A). In contrast, T reg cells were seen throughout the 
lymphocyte aggregates of granulomas (  Fig. 2   and Fig. S1). 
Only rarely, especially at late time points (    150 d after 
infection), were T reg cells observed to be directly interact-
ing with clusters of infected cells (Fig. S1 C). Overall, these 
results show that many of the T reg cells within the lungs of 
  Mtb  -infected mice are located within granulomas, which is 
where tuberculous bacilli live, and that they are controlled 
by the immune system. At a given point in time, however, 
very few of these T reg cells are interacting directly with 
the infected cells, but instead are located in lymphocytic 
  Figure 3.     Foxp3  cells do not make infl  ammatory cytokines after 
  Mtb   infection. 91 d after infection, cells from the lung and pLNs were 
stained for IFN-      and  TNF-     after stimulation for 4 h with anti-CD3 and 
-CD28 or media controls in the presence of monensin. Plots are gated on 
live CD4  cells. The percentage of FoxP3-GFP  –  negative or Foxp3-GFP  
cells that stain positive for the cytokines are shown. Representative FACS 
plots are shown for fi  ve independent experiments with two to three mice 
per  group.   JEM VOL. 204, September 3, 2007 
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WT C57BL/6-Thy1.2      (as a control) or Foxp3KO-Thy1.2      
bone marrow (  Fig. 5 A  ).   After a 10-wk reconstitution, chi-
meras were bled and the relative ratios of Thy1.1/Thy1.2 
expression were compared. As shown in   Fig. 5 B  , time point 1 
(  Fig. 5 B, 1  ), mature T cells expressing either Thy1.1 or 
Thy1.2 developed at an     55:45 ratio. 1 wk before infection, 
mice were treated with anti-Thy1.1 antibody to remove 
Thy1.1     T cells. In both the control (Thy1.1WT/Thy1.2WT) 
and the experimental (Thy1.1WT/Thy1.2KO) chimeras, the 
only T cells that remained were Thy1.2      cells. Thus, as shown 
in   Fig. 5 B   (2; top), 7 d after depletion, uninfected experimental 
chimeras were successfully depleted of      95% of the Thy1.1      
T cells that could express Foxp3. 
  Experimental chimeras [KO:WT] and controls [WT:WT] 
were infected with an aerosol dose of   Mtb   1 wk after deple-
tion with anti-Thy1.1. After infection, mice were treated 
  Foxp3  cells at sites of infection express altered cell 
surface phenotypes 
  To determine if the expansion of T reg cells during tuber-
culosis is associated with a change in their cell surface phe-
notype, we evaluated the expression of several activation 
markers. Consistent with previous reports (  29  ), T reg cells in 
uninfected mice displayed a surface phenotype characteristic 
of antigen-experienced T cells; most are CD44  hi  , CD25  hi  , 
CD62L     , and also express high levels of      7 integrin and 
CD103. These markers did not change signifi  cantly on the 
T reg cells that accumulated in the lung and pLN during 
tuberculosis (unpublished data). Expression of some activa-
tion markers and costimulatory molecules, however, was 
altered after infection. The percentage of Foxp3      CD4      
cells expressing inducible costimulatory molecule (ICOS) 
increased by      50% in the pLNs, but not in the mLNs (  Fig. 4, 
A and B  ). T reg cells in the lung contained relatively high 
levels of ICOS, even in uninfected mice, but expression was 
up-regulated even further during tuberculosis (  Figs. 4, A and B  ).   
The expression of the inhibitory receptor PD-1 also changed 
on the regulatory T cell population at late time points during 
chronic infection. At early time points (    150 d after infection), 
Foxp3-expressing CD4  +   T cells did not express signifi  cantly 
higher levels of PD-1 than T reg cells from uninfected age-
matched controls (unpublished data). At later time points, 
however, T reg cells in the pLNs and lung, but not in the 
T reg cells in the mLNs, expressed higher levels of PD-1 than 
T reg cells at these same sites in age-matched controls (  Fig. 4, 
A and B  ). Thus, T reg cells at sites of infection in tuber-
culosis displayed cell surface phenotypes associated with 
increased activation. 
  T reg cell  –  depleted mice have decreased bacterial burdens 
in their lungs 
  The accumulation of T reg cells at primary sites of   Mtb   infec-
tion leads to the possibility that they may infl  uence the ability 
of eff  ector T cells to promote protective immune responses. 
To determine if Foxp3      cells have the potential to modulate 
immune responses to   Mtb  , we set up conditions to temporally 
deplete Foxp3      cells before infection with   Mtb  . As most Foxp3      
T reg cells express CD25, depletion with anti-CD25 antibody 
is a common experimental approach, but depletion is incom-
plete because not all T reg cells express high levels of CD25     , 
and because some Foxp3-expressing cells survive, but simply 
down-regulate CD25 after antibody treatment (  30, 31  ). This 
approach is also problematic because some CD25      eff  ector T 
cells may also be eliminated by this treatment. These reasons may 
explain why other groups have not seen a change in the bacterial 
load in mice that have been depleted of CD25      T cells before 
(  23  ) (unpublished data; Flynn, J., personal communication) or 
after (unpublished data; Kornfeld, H., personal communication) 
infection with   Mtb  . 
  To facilitate a more complete removal of Foxp3      cells, 
we generated a mixed bone marrow chimeric system. We 
reconstituted an irradiated WT C57BL/6-Thy1.1      host with a 
mixture of WT C57BL/6-Thy1.1      bone marrow and either 
  Figure 4.     Foxp3  cells up-regulate activation markers at the site 
of infection. (A) Cells from lung, pLNs, and mLNs of   Mtb -infected  mice 
(solid line) or uninfected controls (gray area) were stained for CD4 and 
ICOS (64 d after infection) or PD-1 (242 d after infection). Histogram plots 
are gated on live CD4 FoxP3-GFP  cells. Representative FACS plots are 
shown for eight independent experiments with two to three mice per 
group. (B) FACS analysis of ICOS and PD-1 expression among CD4 FoxP3  
cells from indicated organs of   Mtb  -infected (shaded bars) or uninfected 
mice (open bars). The percentage of cells expressing ICOS was calculated 
from the gate indicated on graphs in A. PD-1 mean fl  uorescence intensity 
(MFI) was calculated from all CD4  Foxp3  cells. Increased ICOS expression 
at sites of infection was seen at all time points examined (between 21 and 
242 d after infection) in all experiments (  n     8). In contrast, increased PD-1 
expression was seen in 3 of 3 experiments performed 150 d after infec-
tion, but expression was not increased in 2 of 2 experiments at earlier 
time points.     2164 T REGULATORY CELLS AND TUBERCULOSIS | Scott-Browne et al.
cells in these mice at the time of infection (  Fig. 5 B  ), the 
percentage of CD4      cells expressing Foxp3 had almost re-
turned to normal levels at the time of analysis (23 d after 
infection;   Fig. 5 D  ). 
  Consistent with the fi  ndings in a recent study in which 
T reg cells were eff  ectively eliminated in genetically manipu-
lated mice (  32  ), we observed signs of robust immune activa-
tion in our Thy1.1-depleted chimeras. Even in uninfected 
mice, LNs in T reg cell  –  depleted chimeras were 10 times 
larger than in mock-depleted mice (unpublished data). In ad-
dition, fourfold more CD4      T cells in the pLNs, and almost 
twofold more CD4      T cells in the lungs, expressed high lev-
els of CD44 (  Fig. 5 E  ), suggesting activation of a polyclonal, 
and possibly autoreactive, population of T cells. These signs 
of autoimmunity were observed in experimental [KO:WT] 
chimeras that were depleted of T reg cells, whether or not 
they were infected with   Mtb  , but not in experimental chi-
meras that were not depleted, or in control chimeras. Thus, 
despite the reappearance of Foxp3-expressing cells at the 
time of analysis (  Fig. 5 D  ), the eff  ective elimination of the 
with weekly injections of anti-Thy1.1 in an attempt to de-
plete residual or rebounding cells. 23 d after infection, mice 
were killed and analyzed for T cell function and CFU of   Mtb   
in the lungs and spleen. Despite weekly treatment with the 
depleting antibody, treatment was insuffi   cient to maintain 
complete depletion in some tissues in the experimental chimeras. 
In the pLNs of infected mice,     20% of the T cells expressed 
Thy1.1 (  Fig. 5 B, 3  , top left), whereas in the lungs,   <  10% ex-
pressed Thy1.1 (  Fig. 5 B, 3  , top right). This was true in un-
infected experimental chimeras as well (unpublished data). In 
control [WT:WT] chimeras that were depleted of Thy1.1-
expressing cells, the remaining WT Thy1.2      cells could express 
Foxp3, and the rebound of Thy1.1-expressing cells after deple-
tion was not observed (  Fig. 5 B, 3  , bottom). A high percentage 
of the rebounding Thy1.1     CD4      T cells in the [KO:WT] 
chimeras expressed Foxp3 (45.2% in the lung and 64.7% in 
the pLNs;   Fig. 5 C  ), suggesting that the homeostatic expansion 
of Foxp3-expressing cells was one of the factors driving the 
rebound of Thy1.1-expressing cells in T reg cell  –    depleted 
chimeras. In fact, despite the eff  ective elimination of T reg 
  Figure 5.     Depletion of T reg cells in bone marrow chimeric mice. (A) Schematic of mixed bone marrow chimeras and depletion of T reg cells. Mixed 
bone marrow chimeras were generated between Thy1.1  B6 and Thy1.2  Foxp3KO (designated [KO:WT]) or between Thy1.1  B6 and Thy1.2  B6 control 
(designated [WT:WT]), followed by a 7-d depletion of Thy1.1  T cells, infection with   Mtb   on day 8, and sacrifi  ce 23 d after infection (31 d after depletion). 
Mice were analyzed at time points indicated by encircled numbers. Chimeras were analyzed in the blood after reconstitution and before depletion with 
anti-Thy1.1 (time point 1) and 7 d after depletion of Thy1.1+ cells (preinfection; time point 2). They were subsequently killed 23 d after infection, and the 
lungs, pLNs, mLNs, and spleens were analyzed (time point 3). (B) FACS analysis of bone marrow chimeras at various time points, as designated in A. Plots 
are gated on live, TCR       cells from the indicated tissue, and the percentage of total live cells is shown. Data shown are representative plots of three to 
fi  ve mice in each group from two independent experiments. (C) FACS analysis of CD44 and FoxP3 expression from CD4  cells. CD4  cells in lung or pLN 
from mock or Thy1.1-depleted,   Mtb  -infected, [KO:WT] chimeric mice were compared for CD44 and FoxP3 expression among Thy1.1  and Thy1.2  cells. 
FACS plots are gated on live CD4  cells and separated into Thy1.1  or Thy1.2  events for analysis. (D) Comparison of frequencies of Foxp3 CD4  T cells 
in different tissues from   Mtb  -infected mock or Thy1.1-depleted chimeric mice (KO:WT). Data shown are the percentages of Foxp3  cells, as determined 
by intracellular staining for Foxp3, within the CD4  populations from pooled samples from the lung, pLNs, or mLNs from each group (three to four mice 
per group), or the mean of three to four spleens per group   the SD 23 d after infection. (E) Comparison of CD44  hi -expressing  CD4  cells in pLN and lung 
from uninfected mock or Thy1.1-depleted chimeric mice (KO:WT). Data shown represent the percentages of CD44  hi   cells within the Thy1.2 CD4  popula-
tions of Thy1.1-depleted (shaded bars) or mock-depleted (open bars) mice.     JEM VOL. 204, September 3, 2007 
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from the situation during persistent infection with   L. major  , 
where the percentage of T reg cells also increases dramatically 
in the LNs, draining the site of infection (  12  ). Nevertheless, 
the accumulation of T reg cells within pulmonary granu-
lomas during tuberculosis raises the possibility that these cells 
play a role in suppressing immune responses at this site. A re-
cent study shows that signals mediated through DC-SIGN, 
which is an important receptor for   Mtb   on macrophages and 
dendritic cells (  33, 34  ), promote the diff  erentiation of den-
dritic cells into a tolerogenic phenotype and may help explain 
the expansion of T reg cells during tuberculosis (  35  ). 
  In addition to displaying increased proliferation, T reg cells 
at the site of   Mtb   infection (but not distal to the site of infec-
tion) change their cell surface phenotype, providing further 
evidence for the activation of these cells during tuberculosis. 
The cell surface molecule that is consistently up-regulated at all 
time points after infection is ICOS, which is a costimulatory 
T regulatory population in the experimental chimeras before 
their infection, and likely for substantial period of time there-
after (even for 2  –  3 wk), was supported by their development 
of robust autoimmune activation. We believe that the acti-
vated immune response in these mice may explain why some 
Thy1.1-expressing cells rebounded in the T reg cell  –  depleted 
chimeras, but not in the depleted controls, as the elevated 
immune activation may have facilitated an immune response 
against the depleting antibody, rendering it ineff  ective in these 
animals at later time points. 
  The bacterial loads were compared between depleted in-
fected experimental chimeras and mock-depleted experimental 
chimeras. The bacterial load in the spleen showed no statistical 
diff  erence between the two groups (  Fig. 6 A  ); however, the 
lungs displayed lower CFU values after depletion of T cells 
capable of expressing Foxp3 (    0.9 log CFU less in experi-
ment 1 and     1.1 log CFU less in experiment 2;   Fig. 6 B  ).   The 
lower CFU in T reg cell  –  depleted chimeras was correlated with 
a higher percentage of activated T cells in the lung (  Fig. 5 C  ) 
with the capacity to rapidly produce IFN-      in response to 
polyclonal stimulation (    17% of CD4      T cells in the depleted 
lungs produced IFN-      after stimulation with PMA and iono-
mycin, compared with only     9% in the mock-depleted lungs; 
  Fig. 6 C  ). However, the number of eff  ector T cells produc-
ing IFN-      in response to the MHC class II  –  restricted,   Mtb  -
specifi  c peptide, ESAT-6  1-20   was not increased in either the 
lung or the pLN (  Fig. 6 C and D  ), probably because the re-
duced bacterial load resulted in reduced stimulation of T cells 
specifi  c for this peptide. Overall, these results demonstrate that 
T reg cells have the capacity to suppress immune responses that 
control   Mtb  , especially in the lung. 
    DISCUSSION   
  It is becoming increasingly clear that Foxp3-expressing T reg 
cells are not only critical for suppressing immune responses to 
self-antigens and preventing autoimmunity, but also regulate 
immunity to foreign antigens, especially derived from patho-
gens that establish persistent infections, including   L. major  , 
  H. pylori  , hepatitis C, and HIV (  11  ). We track the activity of 
Foxp3-expressing T reg cells after aerosol infection of mice 
with   Mtb  . 
  The transcription factor Foxp3 is exclusive to TCR-                
in uninfected mice and is expressed primarily by a subset of 
CD4      T cells (  25  ); we fi  nd this is true even during chronic 
infection with   Mtb  . We have observed a signifi  cant accumu-
lation of T reg cells within the lungs and pLNs that parallels 
the accumulation of nonregulatory CD4      T cells at these sites 
of infection. We have shown that some of this accumulation 
is caused by increased proliferation, as T reg cells in the pLNs 
of infected mice show an increased level of BrdU incorpor-
ation compared with cells in distal sites. During persistent in-
fection, T reg cells continue to accumulate at these infected 
sites at a rate that remains similar to the rate of non  –  T reg 
cells. Therefore, although the absolute number of T reg cells 
increases dramatically at these sites, their percentage among 
the CD4      T cells does not change signifi  cantly. This diff  ers 
  Figure 6.     Reduced   Mtb   CFU in lungs of T reg cell  –  depleted mice. 
(A and B) CFU analysis was performed 23 d after infection in Thy1.1-
 depleted  (fi  lled diamonds) or mock-depleted (open diamonds) mice in the 
spleen (A) or lung (B), as indicated. CFU counts from each organ were 
determined from 10-fold serial dilutions, and the numbers of viable bac-
teria are shown for each mouse from two independent experiments (**, P   
0.01; *, P   0.05). The limit of detection for these experiments was 100 CFU 
per organ and is indicated on the graph by the dotted line. (C) Analysis 
of IFN-      production by CD4  cells from lungs or pLNs from mock or de-
pleted [KO:WT] chimeras. Data represent analysis of pooled lung cells 
from all mice in each group, or, in the case of pLNs, from individual mice, 
representative of each group. Percentage of IFN-     – producing  cells  (gated 
on CD4  cells) is shown after in vitro restimulation with media alone, 
PMA/ionomycin, or ESAT6  1-20   peptide. (D) IFN-      production by CD4  cells 
in the pLN. The percentage of pLN CD4  T cells producing IFN-      after  in 
vitro restimulation with media alone, ESAT6  1-20   peptide, or PMA/ionomycin. 
Using the same gates shown in C, data from each individual mouse 23 d 
after infection from Thy1.1-depleted (fi  lled diamonds) or mock-depleted 
(open diamonds) mice are represented.     2166 T REGULATORY CELLS AND TUBERCULOSIS | Scott-Browne et al.
response during tuberculosis remains an important question 
that needs to be addressed. Nevertheless, this reduction in the 
bacterial load after T reg cell depletion suggests that Foxp3      
cells have the capacity to suppress immune responses that 
control   Mtb  . 
  In our experiments, T reg-depleted mice infected with 
  Mtb   exhibited a lower bacterial load in the lungs, but had 
similar, or fewer, numbers of pathogen-specifi  c eff  ector 
T cells. This diff  ers from reports using other pathogens 
in which T reg-depleted mice contained more pathogen-
specifi  c cells ( 11  ). We believe this diff  erence may be explained 
by the relative abundance of pathogen-derived antigens in 
diff  erent infections. During tuberculosis, compared with 
other infections, the slow rate of antigen presentation seems 
to profoundly limit T cell proliferation, and the degree of 
T cell expansion is highly correlated with the bacterial load. 
Whereas the secondary T cell response to most infections is 
higher than the primary response, despite better control of 
the infection (  48, 49  ), this is not the case for   Mtb  . During 
tuberculosis, memory mice mount a smaller secondary T cell 
response than do mice responding to   Mtb   for the fi  rst time 
because they halt bacterial growth sooner and have a lower 
bacterial load (  5  ). Thus, it is possible that T reg cell  –  depleted 
mice infected with   Mtb   would have relatively high numbers 
of pathogen-specifi  c T eff  ector cells if they were compared 
with mice with normal numbers of T reg cells and the same 
bacterial load. In support of this idea, Quinn et al. (  23  ) have 
shown that anti-CD25  –  treated mice that have a less eff  ectively 
eliminated T reg cell population and no change in their 
bacterial burden display an enhanced IFN-      response to 
  Mtb   antigens. 
  A recent work shows that the vast majority of Foxp3      T 
reg cells at the site of infection in mice persistently infected 
with   L. major   are specifi  c for the parasite (  14  ). Furthermore, 
the study shows that adoptive transfer of these parasite-
  specifi  c T reg cells confers the recipient with a profound 
inability to control the pathogen. It will be very important 
to determine if the T reg cells responding during tuberculosis 
are similarly pathogen-specifi  c, and furthermore, if pathogen-
specifi  c T reg cells are critical for controlling immunity. 
Although most T reg cells were not observed to be directly 
interacting with infected macrophages (Fig. S1), it is still pos-
sible that they recognize   Mtb  -derived antigens presented by 
MHC class II molecules on other antigen-presenting cells or 
that occasional interactions with infected cells in the lung are 
suffi   cient for their activity. If most T reg cells that respond 
during tuberculosis are not pathogen-specifi  c, but simply ex-
pand in response to infl  ammation and tissue damage, then 
manipulating T reg cells function will probably hold little 
potential for preventing or treating tuberculosis because sup-
pressing T reg function would probably result in autoimmunity. 
However, if the T reg cells that are most important for con-
trolling immune responses during tuberculosis are specifi  c for 
  Mtb  , it may be possible to achieve some benefi  cial outcomes by 
circumventing these pathogen-specifi  c T reg cells, especially 
during immunization. 
molecule that is highly expressed on activated T reg cells and 
has been implicated in their suppressive activity (  36  ). A sec-
ond molecule that is dramatically up-regulated on T reg cells 
in the lung and pLNs at very late time points (but not earlier 
time points) after infection is PD-1. PD-1 is an inhibitory 
molecule that is expressed at high levels on eff  ector T cells 
that have been   “  exhausted  ”   by chronic stimulation during 
ersistent infection with lymphocytic choriomeningitis virus. 
Interestingly, blocking PD-1 –  mediated signals restores the func-
tion of these eff  ector T cells and allows them to clear the viral 
infection (  37  ). In tuberculosis, PD-1 appears to be most up-
regulated on T reg cells at late time points (  >  150 d after in-
fection), and is less up-regulated on eff  ector T cells. It is un-
clear whether PD-1 expression on T reg cells would inhibit 
or augment T reg function, or what eff  ect blockade of PD-
1  –  mediated signals would have on   Mtb  -infected mice during 
the late chronic stage of persistent infection. 
  The dramatic accumulation of Foxp3      cells, particularly 
at infected sites, begs the question of whether these cells have 
the potential to limit the ability of the immune system to 
respond eff  ectively and control the infection. Upon deple-
tion of Foxp3      cells, we observed that the bacterial burden 
in the lungs was reduced by     10-fold, whereas the bacte-
rial burden in the spleen did not signifi  cantly change with 
depletion. This result is surprising because it is often easier to 
reduce the bacterial burden in the spleen by immunization 
than to reduce the bacterial burden in the lung (  38, 39  ). It is 
possible that part of this diff  erence may be attributable to a 
slightly more robust rebound of Foxp3-expressing cells in the 
spleen compared with the lung at the time of analysis (  Fig. 5 D  ). 
It is tempting to speculate, however, that another contrib-
uting factor may be the relative importance of T reg cells 
in modulating immunity, specifi  cally in the lung. In support 
of this idea, the lung has been shown to harbor subsets of 
tolerogenic dendritic cells that may prime T reg cells and 
suppress pulmonary infl  ammation (  40  –  46  ). 
  The level of reduction of the bacterial burden in T reg 
cell  –  depleted, naive mice (    1 log) is similar to the reduction 
that is achieved in mice that have been immunized by BCG 
or other comparable vaccines (  2  ). In our system, we achieved 
near-complete elimination of all cells that could potentially 
express Foxp3 and observed signs of profound immune acti-
vation, including lymphadenopathy and activation of the 
majority of T cells, mimicking the phenotype seen in Foxp3-
null animals (  26, 47  ) or adult animals in another system in 
which T reg cells were effi   ciently eliminated (  32  ). Although 
we observed a rebound of some T reg cells in depleted chi-
meras when we analyzed these mice 23 d after infection, it is 
likely that the reappearance of these T reg cells allowed us to 
perform the experiment by keeping the animals alive, as 
adult mice that are effi   ciently and persistently depleted of T 
reg cells have recently been shown to die of autoimmunity 
in 2 wk (  32  ). The polyclonal activation of eff  ector T cells at 
the onset of infection with   Mtb   could have induced a non-
specifi  c activation of macrophages, resulting in reduction 
of bacterial burden. Thus, the specificity of the T reg cell JEM VOL. 204, September 3, 2007 
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a few modifi  cations. In brief, lung or LN cells were stimulated with plate-
bound, anti-CD3 and soluble anti-CD28 (1   μ  g/ml; clone 37.51; BD Bio-
sciences) for 4 h in complete RPMI (RPMI 1640 supplemented with 10% FCS, 
2 mM   l-  glutamine, 10 mM Hepes, 0.5   μ  M 2-ME, 100 U/ml penicillin, and 
100   μ  g/ml streptomycin) in the presence of monensin. Cells were washed, 
stained with anti-CD4, and fi  xed in 2% paraformaldehyde for at least 1 h to kill 
the   Mtb   before removing the cells from the biohazard level 3 facility. Cells were 
subsequently permeabilized and stained with anti  –  IFN-       –  allophycocyanin 
(clone XMG1.2; BD Biosciences) and anti  –  TNF-     -PE (clone MP6-XT22; 
BD Biosciences). In some experiments, cells were permeabilized and stained 
for intracellular Foxp3 using anti  –  Foxp3-APC and an intracellular staining 
kit according to the instructions provided by the manufacturer (eBio-
science). Stained cells were acquired on a FACSCanto and analyzed using 
FlowJo software. 
  BrdU incorporation.       Mtb  -infected and uninfected Foxp3-GFP mice were 
given sterile drinking water containing 0.8 mg/ml BrdU (Sigma-Aldrich) 
that was made fresh and changed daily for 14 d beginning 21 d after aerosol 
infection with   Mtb  . Single-cell suspensions of lymphocytes from lungs or 
LNs (pulmonary or mesenteric) were stained for surface markers, followed 
by intracellular BrdU staining using the BrdU Flow kit (BD Biosciences) 
according to the manufacturer  ’  s instructions. Stained cells were acquired on 
a FACSCanto and analyzed using FlowJo Software. 
  Immunohistochemistry.     Lung tissue was frozen in Cryo-Gel embedding 
medium (Instrumedics, Inc.), cut into 8  –  10-     m sections, mounted on slides 
using the CryoJane Tape Transfer System (Instrumedics, Inc.), and fi  xed 
by immersion in cold acetone (     20  °  C) for 20 min. Slides were rinsed 
with PBS and blocked according to manufacturer  ’  s instructions with an 
avidin/biotin blocking reagent kit (Vector Laboratories) in PBS buff  er also 
containing 1% BSA, 0.05% Tween-80, and 5% normal goat serum. After 
washing the slides in PBS, primary antibodies (including polyclonal rabbit 
anti-Foxp3 (  56  ), nonspecifi  c, polyclonal rabbit IgG [Millipore], anti  –  E-
  cadherin rat monoclonal antibody, ECCD-2 (  57  ), and biotinylated anti-CD4 
[clone RM4-5; BD Biosciences]) were diluted in PBS containing 1% BSA 
and 0.05% Tween-80 for 1 h. Slides were washed in PBS and a secondary 
cocktail containing FITC-conjugated goat anti  –  rabbit IgG (Sigma-Aldrich) 
and either Alexa Fluor 546  –  conjugated streptavidin (Invitrogen) or Alexa 
Fluor 546  –  conjugated goat anti  –  rat IgG (Invitrogen) diluted in a solution 
containing PBS, 1% BSA, 0.05% Tween-80, and 5% normal goat serum was ap-
plied for 30 min. Sections were washed with PBS, and slides were mounted 
with Vectashield mounting medium with DAPI (Vector Laboratories). In 
some experiments, serial sections were mounted on diff  erent slides and one 
slide was processed for immunohistochemistry as described in this paragraph, 
and after acetone fi  xation, the other slide was stained with hematoxylin and 
eosin. Images were acquired using a camera (Eclipse E600; Nikon) equipped 
with a 40     /NA 0.90 objective lens (Nikon) and Retiga EX charge-coupled 
device camera (QImaging). Images were analyzed using Photoshop 7.0 
software (Adobe). 
  Generation of bone marrow chimeras.     Bone marrow was harvested 
from C57BL/6, FoxP3  °  , and C57BL/6.PL mice. Single-cell suspensions 
were made and red blood cells were lysed as previously described (55). Bone 
marrow cells were depleted of T cells using anti-CD3       –  biotin (clone 145-
2C11; BD Biosciences), anti-biotin MACS beads (Miltenyi Biotec), and 
AutoMACS separation (Miltenyi Biotec) according to manufacturer  ’  s 
instructions. Recipient C57BL/6.PL mice were irradiated with 1,000 rads 
using a cesium-source and reconstituted with 2       10  6   T cell  –  depleted bone 
marrow cells at a 1:4 ratio from C57BL/6.PL and C57BL/6 or FoxP3  °  . 10 wk 
after bone marrow reconstitution, the chimerism of the mice was confi  rmed 
by bleeding the mice and cell surface staining their peripheral blood cells with 
anti-CD4, -CD8, -Thy1.1, and -Thy1.2. 
  Depletion with anti-Thy1.1.     Anti-Thy1.1 antibody producing hybrid-
oma (clone 19E12, mouse IgG2b) was grown in serum-free media (HB101; 
  BCG, which is an attenuated strain of   Mycobacterium bovis  , 
is closely related to   Mtb  , and is widely used globally to try to 
prevent tuberculosis. However, its effi   cacy varies greatly in 
diff  erent studies. Interestingly, although BCG seems to have 
some effi   cacy in regions of the world with colder climates, it 
is largely ineff  ective in tropical regions that have high levels 
of exposure to environmental mycobacteria (  6  ). Like   Mtb  , 
  M. bovis  , including   M. bovis   BCG, has evolved to induce a 
  “  limited  ”   immune response in hosts, which facilitates its persis-
tence, and BCG can persist in vaccinated hosts for months or 
years (  50  –  52  ). Because BCG is known to share many anti-
gens with   Mtb  , and also with environmental mycobacteria, it 
will be important to determine the extent to which BCG and 
environmental mycobacteria may prime and maintain popu-
lations of T cells that may cross react with   Mtb  , including T 
reg cells, and control immunity against tuberculosis. If this is 
found to be true, devising strategies to overcome or avoid T 
reg cell  –  mediated suppression may be critical for the design 
of an eff  ective vaccine against tuberculosis. 
    MATERIALS AND METHODS   
  Mice.     Age-matched C57BL/6 or C57BL/6.PL mice were purchased from 
The Jackson Laboratory. FoxP3  °   (backcrossed six generations to C57BL/6) 
and FoxP3-GFP (maintained by intercrossing C57BL/6xJ129 F1 animals) 
mice were previously described (  25, 26  ) and maintained under specifi  c 
pathogen-free conditions at the University of Washington (Seattle, WA). All 
experiments were performed in compliance with the University of Washington 
Institutional Animal Care and Use Committee. 
  Bacteria and aerosol infections.     A stock of   Mtb   strain H37Rv was soni-
cated before use, and mice were infected in an aerosol infection chamber 
(Glas-Col) with     50  –  100 CFU deposited in the lungs of each mouse. In some 
experiments, a recombinant strain of H37Rv (provided by L. Ramakrishnan, 
University of Washington, Seattle, WA) that expressed RFP (dsRed2; 
CLONTECH Laboratories, Inc.) under the control of the constitutive 
msp12 promoter (  53, 54  ) was used. Mice were killed on day 1 after infection 
to determine the infectious dose in each experiment. 
  To determine viable numbers of CFUs, the spleen and one lobe of the 
lung were homogenized in PBS   0.05% Tween-80. 10-fold serial dilu-
tions were made in PBS   0.05% Tween-80 and plated on Mitchison 7H10 
plates. Colonies were counted after 21 d of incubation at 37  °  C, and CFUs 
per organ were determined. 
  Cell surface staining.     Red blood cell  –  depleted, single-cell suspensions of 
intraparenchymal lymphocytes (prepared by collagenase digestion of per-
fused lungs), and cells from spleens and LNs were prepared as previously 
described (  55  ). Fc receptors were blocked with anti-CD16/32 (clone 2.4G2). 
Cells were stained at saturating conditions using antibodies specifi  c for CD4 
(clone RM4-5), CD8 (clone 53  –  6.7), NK1.1 (clone PK-136), TCR      (clone 
H37  −  597), TCR           (clone GL3), CD11b (clone M1/70), CD11c (clone 
HL3), CD25 (clone PC61), CD44 (clone IM7), CD62L (clone MEL-14), 
     7 integrin (clone M293), CD103 (clone M280), ICOS (clone 7E.17G9), 
PD-1 (clone J43), Thy1.1 (clone HIS51), and Thy1.2 (clone 53  –  2.1) ob-
tained from BD Biosciences. Samples were fi  xed in a 2% paraformaldehyde 
solution in PBS for at least 1 h, acquired on a FACSCalibur or FACSCanto 
(BD Biosciences), and analyzed using FlowJo software (Tree Star, Inc.). 
  Intracellular staining.     96-well plates were coated with 50   μ  g/ml anti  –
  hamster IgG (clone G94-90.5; BD Biosciences) overnight at 4  °  C, washed 
three times with PBS, and coated for 1 h at 37  °  C with 1   μ  g/ml anti-CD3 
(clone 145-2C11; BD Biosciences). Intracellular IFN-      staining was per-
formed using a kit as instructed by the manufacturer (BD Biosciences), with 2168 T REGULATORY CELLS AND TUBERCULOSIS | Scott-Browne et al.
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